PI3K INHIBITOR FOR USE IN THE TREATMENT OF BONE CANCER OR FOR PREVENTING METASTATIC DISSEMINATION PRIMARY CANCER CELLS INTO THE BONE
- Application ID: EP12753140
- Status: █ APPLICATION DEEMED TO BE WITHDRAWN
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Novartis Pharma AG is specialized in A61. Novartis Pharma AG is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.